• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

皮下注射特布他林对无症状成年哮喘患者血清钾的影响。

The effect of subcutaneously administered terbutaline on serum potassium in asymptomatic adult asthmatics.

作者信息

Küng M, White J R, Burki N K

出版信息

Am Rev Respir Dis. 1984 Feb;129(2):329-32.

PMID:6364906
Abstract

Several recent reports have linked the administration of beta-adrenergic agents to the development of hypokalemia. This led us to study, under controlled conditions, the effects of a subcutaneous injection of 0.25 mg terbutaline sulfate on serum potassium (K+), sodium (Na+), glucose, and insulin in a group of asymptomatic asthmatics. Heart rate (HR), blood pressure (BP), and forced expiratory volume in one second (FEV) were measured as parameters of beta-adrenergic stimulation. Each of 7 subjects was studied on 2 separate mornings after an overnight fast. Measurements were obtained before and at various time intervals after 0.25 mg) of terbutaline sulfate or 0.25 ml of a normal saline solution (placebo) were injected subcutaneously in a double-blind randomized crossover fashion. Terbutaline injection significantly increased HR and FEV and lowered diastolic BP for a period in excess of 3 h, indicating a prolonged beta stimulatory action of the drug. Significant effects on glucose, K+, and insulin were observed as early as 15 min after terbutaline injection; serum glucose and insulin increased and remained elevated for at least 2 h. Serum K+ fell significantly, reached a peak decline of 14% from the control value at 30 min after the injection and remained decreased for a period in excess of after subcutaneous terbutaline injection should be interpreted in the light of these effects of the drug and that terbutaline should be used with caution in patients prone to hypokalemia.

摘要

最近的几份报告将β-肾上腺素能药物的使用与低钾血症的发生联系起来。这促使我们在可控条件下,研究皮下注射0.25毫克硫酸特布他林对一组无症状哮喘患者血清钾(K+)、钠(Na+)、葡萄糖和胰岛素的影响。测量心率(HR)、血压(BP)和一秒用力呼气量(FEV)作为β-肾上腺素能刺激的参数。7名受试者中的每一位都在禁食过夜后的两个不同早晨接受研究。在以双盲随机交叉方式皮下注射0.25毫克硫酸特布他林或0.25毫升生理盐水(安慰剂)之前和之后的不同时间间隔进行测量。特布他林注射使HR和FEV显著增加,并使舒张压在超过3小时的时间内降低,表明该药物具有延长的β刺激作用。早在特布他林注射后15分钟就观察到对葡萄糖、K+和胰岛素有显著影响;血清葡萄糖和胰岛素增加并至少升高2小时。血清K+显著下降,注射后30分钟时从对照值峰值下降14%,并在超过2小时的时间内持续降低。皮下注射特布他林后的这些效应应结合药物的这些作用来解释,并且特布他林在易患低钾血症的患者中应谨慎使用。

相似文献

1
The effect of subcutaneously administered terbutaline on serum potassium in asymptomatic adult asthmatics.皮下注射特布他林对无症状成年哮喘患者血清钾的影响。
Am Rev Respir Dis. 1984 Feb;129(2):329-32.
2
Effects of sequential doses of parenteral terbutaline on plasma levels of potassium and related cardiopulmonary responses.静脉注射不同剂量特布他林对血钾水平及相关心肺反应的影响。
Am Rev Respir Dis. 1990 Mar;141(3):575-9. doi: 10.1164/ajrccm/141.3.575.
3
The effects of oral and subcutaneous administration of terbutaline in asthmatic patients.特布他林口服与皮下给药对哮喘患者的影响。
Eur J Respir Dis Suppl. 1984;134:181-93.
4
Bronchodilatory and circulatory effects of two doses of a beta2-agonist (terbutaline) inhaled with IPPB in patients with reversible airways obstruction.在可逆性气道阻塞患者中,两剂β2激动剂(特布他林)与间歇性正压通气(IPPB)联合吸入的支气管扩张和循环效应。
Scand J Respir Dis. 1976;57(5):252-8.
5
Bronchodilation and beta 2-selectivity of broxaterol in asthmatics: a crossover, single-blind, terbutaline- and placebo-controlled study.溴沙特罗在哮喘患者中的支气管扩张作用及β2选择性:一项交叉、单盲、以特布他林和安慰剂为对照的研究。
Int J Clin Pharmacol Ther Toxicol. 1992 Oct;30(10):365-70.
6
Bronchodilator tolerance and rebound bronchoconstriction during regular inhaled beta-agonist treatment.规律吸入β-受体激动剂治疗期间的支气管扩张剂耐受性和反跳性支气管收缩
Respir Med. 2000 Aug;94(8):767-71. doi: 10.1053/rmed.2000.0820.
7
Hemodynamic, cardiac, and electrolyte effects of low-dose aerosolized terbutaline sulfate in asthmatic patients.低剂量硫酸特布他林雾化吸入对哮喘患者血流动力学、心脏及电解质的影响
Chest. 1998 Aug;114(2):380-7. doi: 10.1378/chest.114.2.380.
8
Effects of somatostatin and oral potassium administration on terbutaline-induced hypokalemia.
Am Rev Respir Dis. 1989 Jan;139(1):176-80. doi: 10.1164/ajrccm/139.1.176.
9
Hypokalaemic effect of salbutamol and terbutaline in bronchial asthma.沙丁胺醇和特布他林对支气管哮喘的低钾血症作用。
J Assoc Physicians India. 1991 Mar;39(3):301-2.
10
Tracheobronchial clearance in bronchial asthma: response to beta-adrenoceptor stimulation.
Scand J Respir Dis. 1976;57(3):119-28.

引用本文的文献

1
Hypokalaemia in healthy volunteers after single and multiple doses of formoterol or salbutamol.健康志愿者单次和多次使用福莫特罗或沙丁胺醇后的低钾血症。
Clin Drug Investig. 1998;15(6):523-9. doi: 10.2165/00044011-199815060-00009.
2
The effect of intravenously administered salbutamol on serum potassium in asthmatic and nonasthmatic atopic subjects.
J Clin Immunol. 1985 May;5(3):195-203. doi: 10.1007/BF00915511.
3
The mechanism of salbutamol-induced hypokalaemia.沙丁胺醇诱发低钾血症的机制。
Br J Clin Pharmacol. 1987 Jan;23(1):65-71. doi: 10.1111/j.1365-2125.1987.tb03010.x.